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Abstract
Background: Supraventricular arrhythmias after thoracotomy for pulmonary resections are well
documented. There has been considerable interest in their incidence, nature, predictability from
preoperative assessment and treatment. The purpose of this study is to define prevalence, type,
risk factors for post-thoracotomy supraventricular arrhythmias and to assess the efficacy of
amiodarone as an antiarrhythmic drug.
Methods: The records of 250 patients undergoing pulmonary resection for lung cancer during last
two years were followed up in this prospective study with particular attention to possible risk
factors (gender, age, extent and side of resection, diabetes mellitus, hypertension, tobacco smoking,
beta-blocker ingestion). Patients underwent biopsy only were excluded. Once onset of
supraventricular arrhythmia was monitored or documented in the electrocardiogram, intravenous
infusion of amiodarone was started with a loading dose of 5 mg/kg in 30 minutes and a maintenance
dose of 15 mg/kg until remission of it.
Results: Forty-three episodes (21.6%) of supraventricular arrhythmias were documented with
atrial fibrillation being the most common (88.3%). Rhythm disturbances were most likely to develop
on the second postoperative day. Pneumonectomy, lobectomy and age >65 years were the
statistically significant factors. The overall postoperative mortality was 3.2% and 2.3% for the
patients with postoperative supraventricular arrhythmias. In none of the cases did supraventricular
arrhythmia cause cardiac failure leading to death. Sinus rhythm was achieved with amiodarone in
37 out of 43 patients (86%). Electrical cardioversion was necessary for 6 patients who were
hemodynamically unstable. The most common amiodarone-related complication was bradycardia
(13.5%).
Conclusions: Postoperative supraventricular arrhythmias are a common complication in elderly
patients undergoing lung resection surgery (especially pneumonectomy or lobectomy).
Amiodarone is both safe and effective in establishing sinus rhythm.
Background
Concern about cardiac dysrhythmias was a prominent
issue during the early years of thoracic surgery. Since the
first actual documentation of cardiac dysrhythmias after
pulmonary resections in the early 1940 s, there has been
considerable interest in their incidence and nature, their
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predictability from preoperative assessment, the ability to
prevent their development and their treatment [1].
According to the international literature, most dysrhyth-
mias are supraventricular and by far the most common is
atrial fibrillation. The pathophysiologic mechanisms are
not well understood and various factors may occur such as
hypoxemia, right ventricular dilatation and pulmonary
hypertension [2].
Treatment of postoperative supraventricular arrhythmias
after lung resection is a controversial topic. Options differ
whether supraventricular arrhythmias should be treated
with b-blockers, calcium channel blockers or other
antiarrhythmic drugs (amiodarone, ibutilide). Digoxin
has traditionally been used for the prophylaxis of
supraventricular arrhythmias after pneumonectomy but
its efficacy remains unproven [3]. Amiodarone (a class III
antiarrhythmic drug) has been used after lung resection
for cancer in a limited number of studies so far with con-
troversial results due to the implication of the drug in the
development of adult respiratory distress syndrome [4].
The purpose of this study was to prospectively evaluate
patients who will undergo pulmonary resection, in an
effort to determine the incidence and factors related to the
development of supraventricular arrhythmias and to
assess the effectiveness of treatment with amiodarone.
Methods
This research project was approved by the Ethical Com-
mittee of our institution and Aristotle University of Thes-
saloniki (Institutional Review Board of Research
involving Human Subject). Patients undergoing elective
thoracotomy for probable pulmonary resection were
identified and informed written consent for participation
in this study was obtained.
Two hundred and fifty patients were enrolled in this pro-
spective study. All patients in whom pulmonary resection
was possible to be performed were considered for the
study. Exclusion criteria were a heart rate of less than 50
beats per minute, a systolic blood pressure less than 100
mm Hg, chronic atrial dysrhythmia, heart failure or thy-
roid dysfunction. Digitalis, b-blockers, calcium antago-
nists and other antiarrhythmic agents were not allowed
for at least 1 week before operation.
Patients who received drugs (macrolide and fluoroqui-
nolone antibiotics, antipsychotic and anidepressant
drugs, serotonin agonists of the triptan class, cisapride,
dolasetron) that have been reported to be associated with
QT interval prolongation were excluded. A baseline car-
diac assessment was performed on all patients including
cardiac history, physical examination and a 12-lead elec-
trocardiogram (ECG). The exercise tolerance test was indi-
cated in all patients with cardiac symptoms, ECG
modifications and in patients who had had a myocardial
infarction more than 1 year before the time of hospitaliza-
tion. If the test was negative, it was followed by surgery. If
not, it was followed by coronary artery angiography.
Echocardiography was performed in patients who had
had a myocardial infarction more than 1 year before and
whose exercise tolerance test was negative in order to eval-
uate the ventricular function. Patients with ejection frac-
tion >25% were eligible for pulmonary surgery.
Each patient's history of hypertension, diabetes mellitus
and tobacco smoking was carefully noted.
A thoracic epidural catheter was inserted into all patients
before surgery. Postoperative analgesia was maintained
with patient-controlled epidural analgesia with an analge-
sic solution of 0,125% bupivacaine plus fentanyl 2 µg mL-
1 according to the following program: no initial dose,
basal infusion rate 4 mL-1, bolus dose 2 ml and a 10 min
lock out interval.
All patients remained in the Intensive Care Unit under
continuous electrocardiographic monitoring during the
first two postoperative days and later if needed.
The treatment routinely used after thoracic operations was
given as usual ie prophylactic antibiotics (cephalosporin),
subcutaneous low molecular weight heparin, b2 agonists
in aerosol and an H2 antagonist intravenously. Other
forms of treatment were given as required. We did not use
macrolide or fluoroquinolone antibiotics due to their QT
prolonging effects.
Patients with postoperative sinus tachycardia due to pain
or intravascular volume depletion were not included.
Once onset of supraventricular arrhythmia was moni-
tored or ECG documented, intravenous infusion of amio-
darone was started with a loading dose of 5 mg/kg in 30
minutes and a maintenance dose of 15 mg/kg until remis-
sion of it.
Supraventricular arrhythmia was considered as ended
when sinus rhythm was restored for more than 24 hours
and amiodarone was interrupted. Thus, length of amio-
darone infusion depended on duration of supraventricu-
lar arrhythmia.
Continuous data was analyzed using independent Stu-
dent's t-test when two sets were compared. Categorical
data was analyzed using x2 analysis or Fisher's exact test
(for data sets with one or more cells < or = 5). In all
instances, p < 0.05 was considered statistically significant.BMC Surgery 2004, 4 http://www.biomedcentral.com/1471-2482/4/7
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Results
Two hundred and fifty patients (209 men – 41 women)
whose age ranged from 39 to 74 years (mean: 63.1 ± 7.2
years) were included in this study.
Forty eight patients underwent pneumonectomy, 105 a
lobectomy, 46 a wedge resection and 51 had an open
biopsy. Patients with biopsy were removed from the
study. The smaller incision and the little amount of lung
removed may have a low impact on development of
supraventricular arrhythmias and therefore the inclusion
of these patients could decrease the real incidence of post-
operative occurence of supraventricular arrhythmias mis-
leading the results.
Forty-three (21.6%) of the 199 patients developed
supraventricular tachyarrhythmia with atrial fibrillation
being the most common (38/43 patients, 88.3%). Three
patients developed atrial flutter and 2 atrial flutter/fibril-
lation.
The incidence of supraventricular arrhythmias by surgical
procedure and side of resection is shown in table 1. Statis-
tical analysis revealed that there is a high incidence of
supraventricular arrhythmias in patients undergoing
pneumonectomy (p < 0.001) and lobectomy (p < 0.01)
versus other type of resections. The side of resection seems
to play no role (right side: 26/114 patients 22.8% versus
left side: 17/85 patients 20%, p value: 0.383) at least in
our material.
Supraventricular arrhythmia occurred in 30 men (18% of
the male population) and in 7 women (17% of the female
population) (p: 0.416). Twenty-two (33.8%) of the 65
patients aged 65 years or over and 15 (11.1%) out of the
134 younger patients developed supraventricular arrhyth-
mia (p < 0.001). Eleven (17.4%) of the 63 patients with
history of hypertension and 5 (17.8%) of the 28 patients
with diabetes mellitus developed supraventricular
arrhythmia, whereas 26 (19.1%) and 32 (18.7%) of them
with no history of hypertension or diabetes mellitus did
Table 1: Incidence of supraventricular arrhythmias by type and side of resection.
Resection side Resection type n:199 Incidence of supraventricular arrhythmias
Right Pneumonectomy 20 10/20 50%
Bilobectomy 19 4/19 21.1%
Upper Lobectomy 29 7/29 24.2%
Lower Lobectomy 20 3/20 15%
Middle Lobectomy 2 0/2 0%
Wedge Resection 24 2/24 8.3%
Left Pneumonectomy 28 11/28 39.2%
Upper Lobectomy 23 3/23 13%
Lower Lobectomy 12 2/12 16.6%
Wedge Resection 22 1/22 4.5%
Table 2: Risk factors for supraventricular arrhythmias and their statistical significance. SA(+): patients with postoperative 
supraventricular arrhythmias. SA(-): patients with no postoperative supraventricular arrhythmias. p values less than 0.05 are 
statistically significant.
Risk factor SA (+) SA (-) p value
Male (n:166) 30/166 136/166 0.416
Female (n:33) 7/33 26/33
Age > 65 years (n:65) 22/65 43/65 <0.001
Age < 65 years (n:134) 7/134 127/134
Hypertension (+) (n:63) 11/63 52/63 0.473
Hypertension (-) (n:136) 26/136 110/136
Diabetes Mellitus (+) (n:28) 5/28 23/28 0.576
Diabetes Mellitus (-) (n:171) 32/171 139/171
Tobacco (+) (n:165) 31/165 134/165 0.548
Tobacco (-) (n:34) 6/34 28/34
Beta-blockers preop (+) (n:25) 4/25 21/25 0.513
Beta-blockers preop (-) (n:174) 32/174 142/174BMC Surgery 2004, 4 http://www.biomedcentral.com/1471-2482/4/7
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not (p: 0.473 and p: 0.576 respectively). Thirty-one
(18.7%) of the 165 patients who were smokers and 6
(17.6%) out of 34 non-smokers developed supraventricu-
lar arrhythmia (p: 0.548). Four (16%) of the 25 patients
who received beta-blockers preoperatively and 32
(18.3%) of 174 who did not, developed supraventricular
arrhythmia (p: 0.513). The overall incidence of supraven-
tricular arrhythmias according to possible risk factors and
its statistical significance is shown in table 2.
The supraventricular arrhythmias lasted from less than 1
day to 6 days with an average of 2.6 days. The peak inci-
dence for the first occurrence of dysrhythmia was on post-
operative day 2 and 3 (65.7% and 20.1% respectively).
Only 2 patients in this study population experienced the
initial onset after 5th postoperative day.
Sinus rhythm was achieved with amiodarone in 37/43
patients (86%). The remaining 6 patients (3 of them
underwent pneumonectomy and the other 3 lobectomy)
received electrical cardioversion due to the fact that they
were hemodynamically unstable. Two of them (both had
undergone pneumonectomy) discharged home with per-
sistent atrial fibrillation and per os antiarrhythmic and
anticoagulant treatment. The most common side effect
because of the use of amiodarone was bradycardia (<50
beats per minute) (5 out of 37 patients – 13.5%). None of
the patients receiving amiodarone developed adult respi-
ratory distress syndrome, blurred vision or worsening of
the arrhythmia.
The overall postoperative mortality was 3.2% (8/250
patients, 4 had myocardial infarction, 1 pulmonary
embolism, 3 respiratory infection) and 2.3% (1/43
patients) for the patients with postoperative supraven-
tricular arrhythmias. This patient had undergone
pneumonectomy and developed supraventricular
arrhythmia on the 2nd postoperative day. He also devel-
oped bronchopleural fistula (15th postoperative day) and
died from respiratory insufficiency due to pulmonary
infection after major thoracoplasty. In none of the cases
supraventricular arrhythmia determined cardiac failure
leading to death. All patients were followed up every 2
months for 5–24 months and 3 of them who had experi-
enced supraventricular postoperatively had a new onset
again.
Discussion
The observation that thoracotomy performed for non car-
diac reasons is often complicated by postoperative
supraventricular arrhythmias, dates back more than 50
years. The etiology remains unclear and is almost certainly
multifactorial, with the postoperative hyperadrenergic
condition and atrial distention as probably most impor-
tant pathophysiologic factors.
The majority of reports in the literature are retrospective
with the incidence of dysrhythmias determined by chart
review with its inherent lack of sensitivity. The reported
incidence of dysrhythmias after thoracotomy also varies
(10–28% in the international literature) [5,6] in part
because of definition of dysrhythmias and methods of
detection. In this study we purposefully excluded sinus
tachycardia often related to presence of pain or intravas-
cular volume depletion. In our material 43 (21.6%) out of
199 patients developed supraventricular arrhythmia with
atrial fibrillation being by far the most common (88.3%).
This is in agreement with all recently published studies.
Numerous authors [7,8] have suggested that the time of
peak onset of development of postoperative dysrhythmias
is during the 2nd postoperative day and this also con-
firmed by our study (65.7% of the patients had the onset
of the arrhythmia on the 2nd postoperative day). In con-
trast Richie and colleagues [9] reported that the most com-
mon time for onset of supraventricular arrhythmia is
during the first postoperative day.
According to the literature, previously stated risk factors
for the development of supraventricular arrhythmias after
pulmonary resection include increasing age, sex, side of
procedure, extent of resection, history of diabetes melli-
tus, hypertension, beta-blockers ingestion and previous
cardiopulmonary disease, anesthetic agents and preopera-
tive pulmonary functional status. Many authors experi-
enced opposite opinions to these factors [10-12]. In our
study increasing age (>65 years) and the extent of pulmo-
nary resection were the only statistically significant factors
as we excluded patients with previous history of cardiop-
ulmonary disease.
The extent of pulmonary resection as a risk factor for
supraventricular arrhythmias has been a standard for
many studies [13,14]. Surgical factors are related to the
destruction of cardiac nervous structures. Both sympa-
thetic and parasympathetic cardiac nerves innervate the
heart. The vagal and sympathetic fibres emerge, from left
to right sides, to form cardiac plexus located between the
aortic arch and the tracheal bifurcation. Their filaments
accompany the coronary arteries and their branches. The
extent of pulmonary resection could determine direct
damage to the above mentioned anatomic structures by
the dissection of pulmonary hilum during lung resection
or hilar and mediastinal node sampling. The significance
of these structures was also confirmed by Haissaguerre
and colleagues [15] who studied a population of non-sur-
gical patients affected by frequent paroxysms of atrial
fibrillation. Electrophysiological study proved that
pulmonary veins, especially in their proximal tract, are
covered by myocardial tissue, with electrical properties
which can generate ectopic beats with consequent atrialBMC Surgery 2004, 4 http://www.biomedcentral.com/1471-2482/4/7
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fibrillation. So, surgical knots to the wall of pulmonary
veins or other surgical manipulations could probably
cause mechanical or ischaemic damage to the zone which
is often covered by myocardial excitable tissue. This could
generate ectopic beats and atrial fibrillation. No mortality
was directly attributed to dysrhythmia. Others have
shown mortality associated with dysrhythmia after thora-
cotomy. Recently, Amar and colleagues [3] have approved
that early supraventricular dysrhythmias after resection of
non- small cell lung cancer is associated with poor long-
term survival, although this finding has to be confirmed
by more studies.
Treatment of postoperative supraventricular arrhythmias
after pulmonary resection remains a controversial topic.
Supraventricular tachyarrhythmias respond well to rate
control drugs such as beta-blockers (esmolol, metoprolol)
or calcium channel antagonists (diltiazem, verapamil).
Class III antiarrhythmic drugs (amiodarone, ibutilide)
have been used recently with satisfactory results although
there are different opinions [4,16].
Beta-blockers are preferred in patients with ischemic heart
disease but may be relatively contraindicated in patients
with proven bronchospastic potential, in those with con-
gestive heart failure, severe sinus bradycardia or high
degree AV-block [17]. Calcium channel blockers are con-
traindicated in patients with Wolff-Parkinson-White syn-
drome since they can accelerate the ventricular rate with
atrial fibrillation [11]. Of the class III antiarrhythmic
drugs, ibutilide has been used currently with moderate
success to convert acute atrial fibrillation in 57% of
patients after cardiac surgery, however polymorhic ven-
tricular tachycardia was reported in 1.8% of patients and
was attributed primarily to electrolyte imbalance [18].
Amiodarone has been used in recent studies in the man-
agement of patients with supraventricular arrhythmia
with great success. Ciriaco and colleagues [8] report
90.9% success in establishing sinus rhythm with no side
effects. This is in agreement with our study, where amio-
darone established sinus rhythm in 86% of the patients
with most common side effect bradycardia (<50 beats per
minute) in 13.5% of the patients. Only 6 patients
required electrical cardioversion due to the fact that they
were hemodynamically unstable. In contrast Van
Mieghem and colleagues [4] report that amiodarone may
be implicated in the development of adult respiratory dis-
tress syndrome after lung surgery and especially
pneumonectomy.
Because of the greater incidence of supraventricular tach-
yarrhythmias in the postoperative period most efforts
have focused on prevention. A recent review [17] summa-
rized the results of numerous studies examining the effi-
cacy of a variety of drugs to prevent this complication in
cardiac surgery patients. It is unclear whether prophylactic
treatment against postoperative atrial arrhythmias
improves clinical outcomes or shortens hospital stay and
whether to employ rate control or rhythm control drugs.
But these studies demonstrated also the effectiveness of
beta-blockers and class III antiarrhythmics (amiodarone,
ibutilide) in reducing the atrial fibrillation incidence after
cardiac operations (valvular surgery, coronary artery by
pass grafting) [19,20]. Amar and colleagues [21] pub-
lished the first large, randomized control trial to demon-
strate that diltiazem clearly prevents occurence of atrial
fibrillation after major thoracic operations. Lanza and col-
leagues [22] demonstrated that low dose oral amiodarone
prophylaxis significantly reduces the incidence of atrial
fibrillation after pulmonary resection. Other randomized
control trials to test prophylactic effects of the drugs are
mandatory to confirm these results in patients after major
thoracic non-cardiac operations.
Conclusions
The present study confirms previous data that supraven-
tricular arrhythmias are common in the postoperative
period following thoracotomy for lung cancer. The results
confirmed the great importance of the extent of surgical
resection and increasing age as risk factors. Amiodarone is
both safe and effective in establishing and maintaining
sinus rhythm.
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